Blue Horseshoe Stocks: INFI Review & More

Infinity Pharmaceuticals, Inc. INFI

The stock with the most notable performance from yesterday morning’s watchlist was definitely INFI, which began trending up in the premarket, and continued its climb throughout the entire session.

The stock traded up from a low of 2.44 to 3.75, which works out to an intraday rise of 54% and it came on roughly 38X its monthly average volume. An early pullback from profit taking this morning would be a likely scenario, but if INFI can find support at a higher point than yesterday’s low, from



AcelRx Pharmaceuticals, Inc. ACRX

After the FDA’s rejecion of the company’s ‘Dsuvia” opioid painkiller, ACRX took a monstrous pounding yesterday down to its lowest price in three months.

As you can see on the chart, it fell all the way down to an area of support it had established back in July. We’ll be interested to monitor this play for a bottom, which could come at any time. Moves generated by FDA news, whether positive or negative, tend to be over-exaggerated and are almost always followed by a course correction.


Inotek Pharmaceuticals Corp ITEK

Here we have an example of being extremely ‘early to the party’ as we sometimes say. We alerted on ITEK back in July, after which point it saw a low of .89. It mostly traded sideways throughout the remainder of the summer, but recently began quite an impressive climb.

This morning, the stock hit news highs of 4.15 in premarket trading on news of a proposed merger with a clinical stage gene therapy company. It may have took a few months to realize, but it works out to an increase of 366%

For an added angle going forward, we’ll also signal the ITEK 10/20 $2.50 Calls for possible daytrades and/or swing trades into next week, and the 11/17 $2.50 & $5.00 Calls for a longer term idea.


Extended Watchlist:
SONS, MARK, HSC, DPW, AKS, CLF, RIG, ATNM, MGEN

Blue Horseshoe Stocks: AVEO Recap & More

AVEO Pharmaceuticals, Inc. AVEO

Swinging back around to discuss AVEO is our top order of business this morning after the stock soared to new highs yesterday. We placed this stock on watch on June 23rd, subsequently mentioning it several times.

On the day of our initial alert, AVEO traded for as little as 1.05 per share, and after multiple weeks in a near-contnual uptrend, the gains have been fantastic. Yesterday AVEO reached new four year highs of 3.19, marking an overall swing of 204%

Volume over the same period has been greatly heightened, and yesterday’s close at 3.15 was a strong one, so even though AVEO has had momentum-mover status for several sessions, we’re going to want to continue to watch it closely.


Inotek Pharmaceuticals, Inc. ITEK

We’re always looking for a good bottom-bouncer, which is why we want to take note of ITEK this morning after disappointing study results on the company’s eye drug sent shares tumbling yesterday.

As we point out on the chart snapshot below, the stock has been beaten back into oversold territory, leaving a big gap on the chart. We’ll place it on watch for the filling of that gap, which from present pricing would spell gains of up to 60%


Extended Watchlist:
ATNM, HK, FOLD, TEUM, JAGX, MSDI, OCUL

Blue Horseshoe Stocks: CRGP, Options Recaps & More

Calissio Resources Group, Inc. CRGP

First up this morning is a stock that we called in Friday’s extended watchlist The volatility in CRGP was an excellent target for flippers on Friday, with the stock coming out with a nice initial intraday run before following it up with a couple of subsequent bounces.

It began from a morning low of .0043 from which point CRGP rattled off its first swing up to the high-of-day at .0067; a nice 56% surge. After pulling back to .0045, it ran promptly back to .006 adding another 33% pop. It finished up with a dip back to .005 and 20% run-back to .006.

In total, CRGP’s session produced cumulative gains on the order of 109%, fueled by the news that the company had completed a $14.6M sale of its Mexican copper mine >> READ PR


Inotek Pharmaceutical Corp. ITEK

We tagged ITEK in Thursday’s premarket report, after noticing some FDA-related news hitting the wires, and during that session we would witness a low of 7.66 before the stock took off on an impressive tear that bled into Friday’s trading as well.

On Friday, the momentum carried the stock to a new high of 19.45, which registered as an overnight increase of 154%, so we want to send our congratulations to those of our readers who caught our report and cashed in on that impressive move!


Friday’s Winning Options Ideas

The big winners among the options ideas that we submitted in Friday morning’s report turned out to be the FB Weekly $96-50-97.50 Calls . Every one of the contracts in the range we specified turned up chances at impressive profits. Here’s a breakdown of the gains that were made possible by our timely alert.

The $96.50 Calls came out of the gate with a nice initial 108% move of from .65-1.35. That was followed up by a significant pullback to its daily low of .07 before running hard back to .58; an incredible 728% surge.

The $97 Calls produced similar action, with their first run taking them from .37-.96 (+159%), followed by a dip back to a penny before reaching back to a dime. That second move, like the previously mentioned contracts, was far more pronounced, coming in at a whopping  900%

The 97.50’s did make a move from .22-.52, an intraday gain of 136%, however they ended up too far out of the money to see a second run like the aforementioned plays. Still, their performance was nothing to sneeze at; any way you slice it, our FB Options ideas from Friday were a huge success!


Extended Watchlist:
MNOV (FDA Approval News), OGXI, XUE, SVLC, GDP, PSTI, VLTC